Stocks
Aptevo Therapeutics Inc.APVO
NASDAQHealthcareBiotechnology$4.42-3.28%
A clinical-stage biotechnology company focused on developing novel immunotherapies, particularly bispecific antibodies designed to engage the immune system to target cancer cells. Its pipeline includes investigational treatments for hematologic malignancies built on the company’s proprietary ADAPTIR...
Market Cap: $7.3M52W Range: $3.95 – $1299.60
Congressional Interest in Aptevo Therapeutics Inc. (APVO)
1 member of Congress has disclosed 1 trade in Aptevo Therapeutics Inc. (APVO), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading APVO?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2019-06-24 | STEVE COHEN | sell | $470+ |